Why did TMD.TO stock spike pre-market today?

The spike reflects low prior liquidity and a large trade flow pushing price from C$0.05 to C$1.125, with volume **117,220** versus average **45,936**. No earnings release explains the move, so repositioning and low float dynamics are likely drivers.

What is Meyka AI's grade for TMD.TO stock?

Meyka AI rates TMD.TO with a score out of 100: **64.67**, Grade **B**, Suggestion **HOLD**. The grade factors in benchmark and sector comparisons, key metrics, financial growth, and analyst consensus.

What forecast does Meyka AI give for TMD.TO stock?

Meyka AI's forecast model projects **C$0.45** for TMD.TO stock versus the current reference **C$1.125**, implying **-60.00%**; forecasts are model-based projections and not guarantees.

Should traders buy into the pre-market volume on TMD.TO stock?

Trading on this move carries high execution risk due to thin liquidity and wide spreads. Short-term traders may scalp with strict stops; long-term buyers should wait for company catalysts or regulatory updates.

CA Stocks

TMD.TO Titan Medical Inc. TSX C$1.12 pre-market 04 Feb 2026: high volume signals interest

ByHuzaifa Zahoor February 4, 2026

The TMD.TO stock price is trading at C$1.12 in pre-market activity on 04 Feb 2026 after an intraday swing that pushed the share price from C$0.05 to C$1.125. Volume is elevated at 117,220 shares versus a 50-day average of 45,936, marking a 2.55x relative volume. The move follows no public earnings release today, so trading appears driven by repositioning and low float dynamics in this TSX-listed medical devices developer.